Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Top Cited Papers
Open Access
- 10 August 2017
- journal article
- research article
- Published by Elsevier BV in Cell Stem Cell
- Vol. 21 (3), 374-382.e4
- https://doi.org/10.1016/j.stem.2017.07.010
Abstract
No abstract availableKeywords
Funding Information
- NIH National Cancer Institute (P30 CA008748)
- Conquer Cancer Foundation American Society of Clinical Oncology Young Investigator Award
- Stand Up to Cancer Convergence Program
- National Science Foundation (NSF/SU2C 2015-003)
This publication has 38 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpointThe Journal of cell biology, 2013
- Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerNature, 2012
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- Detectable clonal mosaicism and its relationship to aging and cancerNature Genetics, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsBioinformatics, 2009
- A class of rank test procedures for censored survival dataBiometrika, 1982